Treatment of Levodopa-Related Motor Complications in Parkinson Disease - Flowchart
Treatment of Levodopa-Related Motor Complications in Parkinson Disease - Flowchart Parkinson Disease Parkinson Disease
«Flowchart»

Treatment of motor complications in Parkinson disease

Treatment of motor complications in Parkinson disease

Treatment of motor complications in Parkinson disease

Treatment of motor complications in Parkinson disease

Discontinue sinemet CR, MAOI, entacapone

Discontinue sinemet CR, MAOI, entacapone

Discontinue sinemet CR, MAOI, entacapone

Levodopa therapy

Levodopa therapy

Levodopa therapy

Levodopa therapy

Dyskinesias

Dyskinesias

Dyskinesias

Motor fluctuations

Motor fluctuations

Motor fluctuations

Reduce levodopa

Reduce levodopa

Reduce levodopa

Add amantadine or amantadine ER, LCIG

Add amantadine or amantadine ER, LCIG

Add amantadine or amantadine ER, LCIG

Consider: zonisamide, clozapine, quetiapine, topiramate, levetiracetam

Consider: zonisamide, clozapine, quetiapine, topiramate, levetiracetam

Consider: zonisamide, clozapine, quetiapine, topiramate, levetiracetam

STN or GPi DBS

STN or GPi DBS

STN or GPi DBS

End

End

End

No improvement

No improvement

No improvement

SC or sublingual apomorphine, inhalable levodopa rescue continuous infusions:


LCIG
SC infusion apomorphine

SC or sublingual apomorphine, inhalable levodopa rescue continuous infusions:


LCIG
SC infusion apomorphine

SC or sublingual apomorphine, inhalable levodopa rescue continuous infusions:


LCIG
SC infusion apomorphine


LCIG
SC infusion apomorphine

Severe motor fluctuations

Severe motor fluctuations

Severe motor fluctuations

Fractionate levodopa or use
ER formulations
Add:


MAOI (rasagiline, selegiline, safinamide)
DA agonist (ER or transdermal formulations)
A2A antagonist (istradefylline)

Fractionate levodopa or use
ER formulations
Add:




MAOI (rasagiline, selegiline, safinamide)
DA agonist (ER or transdermal formulations)
A2A antagonist (istradefylline)


MAOI (rasagiline, selegiline, safinamide)
DA agonist (ER or transdermal formulations)
A2A antagonist (istradefylline) Fractionate levodopa or use